A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Mesothelioma
Related studies linked through entity extraction aliases.
FAPI PET Imaging - An Exploratory Study
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
SELECTmeso A Trial for Patients With Relapsed Malignant Mesothelioma SELECTmeso1 A Trial of BMS-986504 in Patients With MTAP-deficient Relapsed Mesothelioma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A 2-part Phase 1/2 Open-label Trial on ODM-212
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Iparomlimab Plus Tovorilimab Combined With Bevacizumab and Chemotherapy as First-Line Treatment for Advanced Mesothelioma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors.
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Study of Iparomlimab and Tuvonralimab Plus Chemotherapy in Malignant Mesothelioma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Partial Pleurectomy (Surgery) for Unresectable Pleural Mesothelioma
- Status
- RECRUITING
- Phase
- NA
An International Study on Pediatric Patients With Rare Tumors.
- Status
- RECRUITING
- Phase
- N/A
Prospective Data Collection Initiative on Thoracic Malignancies
- Status
- RECRUITING
- Phase
- N/A
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
- Status
- RECRUITING
- Phase
- PHASE1
A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Lead-212 PSV359 Therapy for Patients With Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Alrizomadlin (APG-115) in Subjects With BAP1 Cancer Syndrome and Early-Stage Mesothelioma
- Status
- WITHDRAWN
- Phase
- PHASE2
Phase 1 Dose Escalation and Expansion to Evaluate AROG4-01 in Patients With Advanced Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Agnostic Therapy in Rare Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2
Immune Microenvironment and Gene Expression Profiling in Mesothelioma
- Status
- RECRUITING
- Phase
- N/A
Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU
- Status
- RECRUITING
- Phase
- NA
New Preclinical and Clinical Approaches to Mesothelioma
- Status
- RECRUITING
- Phase
- N/A